BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 1244208)

  • 1. Evidence that C1s participates in the alternative complement pathway.
    Volanakis JE; Schultz DR; Stroud RM
    Int Arch Allergy Appl Immunol; 1976; 50(1):68-80. PubMed ID: 1244208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of an early component of complement and Hageman factor in C3 destruction by zymosan.
    Gigli I; Koethe S; Austen KF
    Clin Immunol Immunopathol; 1975 Jul; 4(2):189-98. PubMed ID: 1170051
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement system in human colostrum: presence of nine complement components and factors of alternative pathway in human colostrum.
    Nakajima S; Baba AS; Tamura N
    Int Arch Allergy Appl Immunol; 1977; 54(5):428-33. PubMed ID: 885627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired c1-inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities. A study of three cases.
    Hauptmann G; Lang JM; North ML; Oberling F; Mayer G; Lachmann P
    Blut; 1976 Mar; 32(3):195-206. PubMed ID: 946413
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemolytic complement activity in normal human donor corneas.
    Mondino BJ; Hoffman DB
    Arch Ophthalmol; 1980 Nov; 98(11):2041-4. PubMed ID: 7002126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement components, C1 activation and disease activity in SLE.
    Sturfelt G; Sjöholm AG; Svensson B
    Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypochlorite-induced alterations to canine serum complement.
    Boyer JT; Wyde P; Bier M
    Clin Exp Immunol; 1975 Aug; 21(2):345-50. PubMed ID: 1102168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
    McLean RH; Townsend K; Michael AF
    Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing of hemolytic complement components in domestic animals.
    Barta O; Hubbert NL
    Am J Vet Res; 1978 Aug; 39(8):1303-8. PubMed ID: 697137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aspirin on the complement system in vitro.
    Hänsch GM; Voigtländer V; Rother U
    Int Arch Allergy Appl Immunol; 1980; 61(2):150-8. PubMed ID: 7351347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complement activation and biological activities].
    Inoue K
    Nihon Saikingaku Zasshi; 1976 Jul; 31(4):535-55. PubMed ID: 988219
    [No Abstract]   [Full Text] [Related]  

  • 12. The human complement system.
    Volanakis JE
    J Oral Pathol; 1975; 4(4):195-221. PubMed ID: 811779
    [No Abstract]   [Full Text] [Related]  

  • 13. [Consumption hypocomplementemia: comparative value of haemolytic and protein estimations of the components of the classical pathway (author's transl)].
    Roncato M; Vial MC; Maillet F; Peltier A
    Nouv Presse Med; 1979 May; 8(20):1657-60. PubMed ID: 112575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical hypocomplementemic vasculitis syndrome in a child.
    Waldo FB; Leist PA; Strife CF; Forristal J; West CD
    J Pediatr; 1985 May; 106(5):745-50. PubMed ID: 2987470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the classical pathway of complement by Hageman factor fragment.
    Ghebrehiwet B; Silverberg M; Kaplan AP
    J Exp Med; 1981 Mar; 153(3):665-76. PubMed ID: 7252410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies on complement inactivation by snake venoms.
    Eggertsen G; Fohlman J; Sjöquist J
    Toxicon; 1980; 18(1):87-96. PubMed ID: 6768170
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation of the alternative pathway of complement by Entamoeba histolytica.
    Ortiz-Ortiz L; Capin R; Capin NR; Sepúlveda B; Zamacona G
    Clin Exp Immunol; 1978 Oct; 34(1):10-8. PubMed ID: 219975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complement abnormalities of lipodystrophy.
    Sissons JG; West RJ; Fallows J; Williams DG; Boucher BJ; Amos N; Peters DK
    N Engl J Med; 1976 Feb; 294(9):461-5. PubMed ID: 1246331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functional inhibition of activated C1 inhibitor in normal human serum causes spontaneous consumption of the complement components C2, C3, C4, and factor B.
    Gronski P; Bodenbender L; Kanzy EJ; Piepenbrock M; Seiler FR
    Immunobiology; 1986 Apr; 171(3):252-62. PubMed ID: 3011651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective deficiency of the second component of complement in a patient with anaphylactoid purpura.
    Gelfand EW; Clarkson JE; Minta JO
    Clin Immunol Immunopathol; 1975 Jul; 4(2):269-76. PubMed ID: 1095265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.